心臟去心房顫動（CRT-D）市場規模、佔有率和成長分析：按設備類型、產品功能、患者類型、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024年全球CRT-D市值為4.873億美元，預計將從2025年的5.2823億美元成長到2033年的10.0707億美元。去心房顫動期（2026-2033年）的複合年成長率預計為8.4%。

全球心臟再同步治療去顫器（CRT-D）市場以植入式裝置為特徵，這些裝置整合了雙心室起搏和去心房顫動功能，用於治療晚期心臟衰竭並降低猝死風險。人口老化導致心臟衰竭患者數量不斷增加，這是推動市場成長的主要因素。臨床試驗的正面結果凸顯了CRT-D的價值，促使其被納入治療指引並擴大保險覆蓋範圍。電池壽命的延長和遠端監測技術的進步減少了併發症，並提高了後續觀察的便利性，從而促進了CRT-D在各種醫療保健系統中的應用。遠端監測的引入能夠及早發現問題，從而減少急診住院次數和整體成本。此外，人工智慧正在透過最佳化個人化治療、支持治療計劃和簡化工作流程來改善臨床療效，從而改變患者選擇和治療結果。

全球心臟再同步去心房顫動（CRT-D）市場促進因素

隨著心臟衰竭發病率的上升，醫療專業人員正在探索基於器械的治療方法，旨在改善嚴重傳導障礙並緩解症狀，這導致符合心臟再同步治療除顫器（CRT-D）治療條件的患者數量顯著增加。儘管接受了常規藥物治療，仍有越來越多的患者出現複雜室性心律不整和持續性症狀，這推動了CRT-D植入的適用性。這種不斷成長的臨床需求促使醫療機構優先評估CRT-D治療方法，從而加速其在心臟護理中的應用。這一趨勢透過促進知情臨床選擇，支持為患者提供適當的器械干預，從而提升了市場需求。

全球心臟再同步去心房顫動（CRT-D）市場的限制因素

CRT-D系統的普及受到高昂的初始成本和複雜的報銷機制的限制，這限制了資源匱乏地區的患者獲取該系統，並導致醫療機構採取保守的採購策略。當保險公司設定嚴格的資格標準或不同地區的報銷金額有差異時，醫療專業人員和機構可能會選擇其他治療方案，或延遲植入手術，直到資金籌措問題明確為止。這些財務挑戰影響採購選擇、醫院財務規劃和臨床醫生轉診行為，而對經濟可行性的擔憂也阻礙了植入計畫在各種醫療機構的推廣，最終導致儘管存在臨床需求，市場成長仍然受到阻礙。

全球去心房顫動（CRT-D）市場趨勢

全球去心房顫動（ CRT）市場正呈現顯著的遠端監測整合趨勢，這主要得益於無線遙測和雲端連接平台的普及應用。這一發展趨勢使得持續監測心律和設備表現成為可能，從而提升植入後追蹤護理水平，並實現對患者健康的主動管理。保險公司和醫療服務提供者日益重視能夠降低再入院率和簡化門診流程的解決方案，這促使製造商開發可互通的生態系統和使用者友善的介面。這種模式轉移正在推動個人化治療協調和遠距離診斷，加快醫療服務的可近性，並促進建立連接醫院系統、居家醫療服務和行動醫療應用的協作模式。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

市場考察

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場吸引力指數
• PESTEL 分析
• 監理情勢

全球去心房顫動（CRT-D）市場規模：按設備類型和複合年成長率（2026-2033 年）分類

• 單腔CRT-D
• 雙腔CRT-D
• 雙心室CRT-D

全球心臟去心房顫動（CRT-D）市場規模：依產品特性及複合年成長率分類（2026-2033 年）

• 無線監控
• 抗心搏過速功能
• 速率自適應起搏

全球去心房顫動顫器（CRT-D）市場規模：按患者類型和複合年成長率（2026-2033 年）分類

• 成年患者
• 兒童患者
• 老年患者

全球CRT（心血管呼吸）去心房顫動（CRT-D）市場規模：以最終用戶和複合年成長率（2026-2033）分類

• 醫院
• 心臟診所
• 居家醫療

全球CRT-D市場規模：依去心房顫動管道及複合年成長率分類（2026-2033年）

• 直銷
• 銷售代理
• 線上零售

全球心臟再同步去心房顫動（CRT-D）市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 2023-2025年營收年比比較

主要企業簡介

• Medtronic
• Boston Scientific
• Abbott Laboratories
• Biotronik
• Biomed Technologies
• LivaNova
• Philips Healthcare
• Elekta
• Zoll Medical Corporation
• St. Jude Medical
• Medifocus
• Oscor
• AtriCure
• Cardiovascular Systems, Inc.
• ELA Medical
• Shiller
• Sorin Group
• Neovasc
• AngioDynamics
• Cook Medical

結論與建議

Global Crt Defibrillator (Crt-D) Market size was valued at USD 487.3 Million in 2024 and is poised to grow from USD 528.23 Million in 2025 to USD 1007.07 Million by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global CRT-D market is characterized by implantable devices that merge biventricular pacing with defibrillation to treat advanced heart failure and mitigate sudden cardiac death. The rising incidence of heart failure in aging populations is a primary driving force behind market growth. Positive outcomes from clinical trials have reinforced the value of CRT-Ds, leading to their inclusion in treatment guidelines and expanded reimbursement. Enhanced technology in battery life and remote monitoring has reduced complications and improved ease of follow-up, increasing adoption across various healthcare systems. The implementation of remote monitoring allows for early identification of issues, lowering emergency admissions and overall costs. Additionally, AI is transforming patient selection and outcomes by optimizing therapy personalization, supporting procedural planning, and streamlining workflows for better clinical results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Crt Defibrillator (Crt-D) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Crt Defibrillator (Crt-D) Market Segments Analysis

Global crt defibrillator (crt-d) market is segmented by device type, product features, patient type, end user, distribution channel and region. Based on device type, the market is segmented into Single Chamber CRT-D, Dual Chamber CRT-D and Bi-Ventricular CRT-D. Based on product features, the market is segmented into Wireless Monitoring, Anti-Tachycardia Functions and Rate Adaptive Pacing. Based on patient type, the market is segmented into Adult Patients, Pediatric Patients and Geriatric Patients. Based on end user, the market is segmented into Hospitals, Cardiac Clinics and Home Care. Based on distribution channel, the market is segmented into Direct Sales, Distributors and Online Retail. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Crt Defibrillator (Crt-D) Market

The rising incidence of heart failure is significantly increasing the number of patients who qualify for CRT-D therapy, as healthcare professionals explore device-based solutions to address severe conduction issues and alleviate symptoms. As a growing number of individuals experience complicated ventricular dyssynchrony alongside ongoing symptoms despite conventional medical treatment, the rate of referrals for CRT-D implantation is on the rise. This expanding clinical requirement drives healthcare providers to emphasize the assessment of CRT-D options, thereby fostering its integration into cardiology practices. Consequently, this trend bolsters market demand by promoting informed clinical choices that favor device interventions for suitable patients.

Restraints in the Global Crt Defibrillator (Crt-D) Market

The adoption of CRT-D systems is hindered by high initial costs and a complicated reimbursement environment, which restrict access in resource-limited areas and lead to conservative purchasing practices among healthcare providers. When insurance payers impose stringent coverage criteria or offer inconsistent reimbursements across different regions, healthcare professionals and facilities may opt for alternative treatments or postpone implantation until funding clarity is achieved. These financial challenges influence procurement choices, hospital financial planning, and clinician referral habits, ultimately impeding market growth despite the existing clinical demand, as concerns over economic viability discourage the expansion of implantation programs in various healthcare settings.

Market Trends of the Global Crt Defibrillator (Crt-D) Market

The global CRT defibrillator market is experiencing a significant trend towards remote monitoring integration, driven by the adoption of wireless telemetry and cloud-connected platforms. This evolution allows for continuous monitoring of cardiac rhythm and device performance, enhancing post-implant follow-up care and enabling proactive management of patient health. Insurers and healthcare providers are increasingly prioritizing solutions that minimize readmission rates and streamline outpatient care pathways, prompting manufacturers to develop interoperable ecosystems and user-friendly interfaces. This paradigm shift supports personalized therapy adjustments and remote diagnostics, facilitating broader access to care and encouraging collaborative models that intertwine hospital systems, home health services, and mobile health applications.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global CRT Defibrillator (CRT-D) Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Single Chamber CRT-D
• Dual Chamber CRT-D
• Bi-Ventricular CRT-D

Global CRT Defibrillator (CRT-D) Market Size by Product Features & CAGR (2026-2033)

• Market Overview
• Wireless Monitoring
• Anti-Tachycardia Functions
• Rate Adaptive Pacing

Global CRT Defibrillator (CRT-D) Market Size by Patient Type & CAGR (2026-2033)

• Market Overview
• Adult Patients
• Pediatric Patients
• Geriatric Patients

Global CRT Defibrillator (CRT-D) Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Clinics
• Home Care

Global CRT Defibrillator (CRT-D) Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors
• Online Retail

Global CRT Defibrillator (CRT-D) Market Size & CAGR (2026-2033)

• North America (Device Type, Product Features, Patient Type, End User, Distribution Channel)
  • US
  • Canada
• Europe (Device Type, Product Features, Patient Type, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Device Type, Product Features, Patient Type, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Device Type, Product Features, Patient Type, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Product Features, Patient Type, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomed Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoll Medical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medifocus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oscor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AtriCure
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiovascular Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ELA Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shiller
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorin Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovasc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations